Cardiovascular mortality in children and young adults with end-stage kidney disease

The Journal of Pediatrics - Tập 141 - Trang 191-197 - 2002
R.S. Parekh1, C.E. Carroll1, R.A. Wolfe1, F.K. Port1
1Departments of Pediatrics and Internal Medicine, Johns Hopkins University, Baltimore, Maryland; National Opinion Research Center, University of Chicago, Illinois; and the Kidney and Epidemiology and Cost Center, Departments of Epidemiology, Biostatistics, and Medicine, University of Michigan, Ann Arbor

Tài liệu tham khảo

Foley, 1998, Clinical epidemiology of cardiovascular disease in chronic renal disease, Am J Kidney Dis, 32, S112, 10.1053/ajkd.1998.v32.pm9820470 USRDS, 1999 Levey, 1998, Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?, Am J Kidney Dis, 32, S5, 10.1053/ajkd.1998.v32.pm9820463 Murphy, 2000, National Vital Statistics Report., vol 48 Parfrey, 1999, The clinical epidemiology of cardiac disease in chronic failure, Am Soc Nephrol, 10, 1606, 10.1681/ASN.V1071606 Foley, 1996, Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease, Kidney Int, 49, 1379, 10.1038/ki.1996.194 Kari, 1998, Effect of enteral feeding on lipid subfractions in children with chronic renal failure, Pediatr Nephrol, 12, 401, 10.1007/s004670050474 Querfeld, 1991, Lipoproteins in children treated with continuous peritoneal dialysis, Pediatr Res, 29, 155, 10.1203/00006450-199102000-00011 Querfeld, 1993, Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease, Pediatr Res, 34, 772, 10.1203/00006450-199312000-00015 Querfeld, 1993, Disturbances of lipid metabolism in children with chronic renal failure, Pediatr Nephrol, 7, 749, 10.1007/BF01213345 Querfeld, 1996, Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency, Eur J Pediatr, 155, 913, 10.1007/BF02282846 Silverstein, 2000, Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients, Pediatr Nephrol, 14, 105, 10.1007/s004670050022 Kimak, 1997, Plasma lipoproteins in patients with chronic renal failure (CRF), Int Urol Nephrol, 29, 597, 10.1007/BF02552207 Johnstone, 1996, Left ventricular abnormalities in children, adolescents and young adults with renal disease, Kidney Int, 50, 998, 10.1038/ki.1996.401 Matteucci, 1999, Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients, Kidney Int, 56, 1566, 10.1046/j.1523-1755.1999.00667.x Mitsnefes, 2000, Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors, Pediatr Nephrol, 14, 898, 10.1007/s004670000303 Mitsnefes, 2001, Changes in left ventricular mass in children and adolescents during chronic dialysis, Pediatr Nephrol, 16, 318, 10.1007/s004670000557 Kimm, 1999, Correlates of lipoprotein(a) in a biracial cohort of young girls, J Pediatr, 135, 169, 10.1016/S0022-3476(99)70018-1 Islam, 1994, Low density lipoprotein cholesterol/apolipoprotein B-100 ratio: interaction of family history of premature atherosclerotic coronary artery disease with race and gender in 7 to 11 year olds, Pediatrics, 94, 494, 10.1542/peds.94.4.494 Furth, 1998, Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients, Semin Dial, 11, 102, 10.1111/j.1525-139X.1998.tb00310.x USRDS, 2001 Perneger, 1993, Cause of death in patients with end-stage renal disease: death certificates vs registry reports, Am J Public Health, 83, 1735, 10.2105/AJPH.83.12.1735